ESC Premium Access

Comparison of P2Y12 inhibitors in atrial fibrillation patients treated by dual-antiplatelet therapy without oral anticoagulant after acute myocardial infarction with percutaneous coronary intervention

Congress Session

About the speaker

Doctor Hyung Ki Jeong

Chonnam National University Hospital, Gwangju (Korea (Republic of))
0 follower

5 more presentations in this session

Real-world clinical data of atrial fibrillation patients treated with direct oral anticoagulants in combination with or without antiplatelet therapy

Speaker: Doctor R. Amiya (Osaka, JP)

Thumbnail

Characterization of major and clinically relevant non-major bleeding in the APEX trial

Speaker: Miss M. Yee (Boston, US)

Thumbnail

Increased major bleeding risk with use of topical miconazole agents among users of oral anticoagulation: A population-level safety study

Speaker: Doctor M. Lamberts (Copenhagen, DK)

Thumbnail

Differences between hospitalised vs. outpatient management amongst european patients with atrial fibrillation: the EORP-AF general long-term registry

Speaker: Doctor M. Proietti (Milan, IT)

Thumbnail

Oral anticoagulants in patients with atrial fibrillation and non-mechanical heart valve disease

Speaker: Mr J. Strange (Hellerup, DK)

Thumbnail

Access the full session

Oral anticoagulants : news from large trials and registries

Speakers: Doctor H. Jeong, Doctor R. Amiya, Miss M. Yee, Doctor M. Lamberts, Doctor M. Proietti...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk